高级检索
余艳琴, 石郑阳, 石继海, 苏征, 傅颖, 高静茹, 郝金奇, 乔友林. 中国大陆居民对HPV疫苗接种态度和行为系统评价[J]. 中国公共卫生, 2022, 38(10): 1348-1354. DOI: 10.11847/zgggws1137419
引用本文: 余艳琴, 石郑阳, 石继海, 苏征, 傅颖, 高静茹, 郝金奇, 乔友林. 中国大陆居民对HPV疫苗接种态度和行为系统评价[J]. 中国公共卫生, 2022, 38(10): 1348-1354. DOI: 10.11847/zgggws1137419
YU Yan-qin, SHI Zheng-yang, SHI Ji-hai, . Attitudes and behaviors about HPV vaccination in mainland Chinese residents: a systematic review and meta-analysis[J]. Chinese Journal of Public Health, 2022, 38(10): 1348-1354. DOI: 10.11847/zgggws1137419
Citation: YU Yan-qin, SHI Zheng-yang, SHI Ji-hai, . Attitudes and behaviors about HPV vaccination in mainland Chinese residents: a systematic review and meta-analysis[J]. Chinese Journal of Public Health, 2022, 38(10): 1348-1354. DOI: 10.11847/zgggws1137419

中国大陆居民对HPV疫苗接种态度和行为系统评价

Attitudes and behaviors about HPV vaccination in mainland Chinese residents: a systematic review and meta-analysis

  • 摘要:
      目的   对中国大陆地区居民HPV疫苗接种态度和行为进行系统评价,为中国大陆地区居民消除宫颈癌提供理论依据。
      方法   检索1995年1月1日 — 2021年1月31日在Pubmed、Medline、CNKI和万方数据库等数据库收录的所有关于中国大陆地区发表的有关HPV疫苗接种态度和行为因素的相关研究,由 2 位研究者独立筛选文献、提取数据资料,文献评分≥5分的文献纳入研究,采用Stata 12.0 软件进行统计分析。
      结果   本文共有 52篇文献纳入研究,总人数为91 762人;研究结果显示,人群对HPV疫苗接种意愿为66.4 %(95 % CI = 66.1 %~66.6 %),其中HPV疫苗接种意愿最高为硕士及以上人群、2016年以后人群,占比分别为65.1 %(95 % CI = 56.9 %~73.4 %)和68.4 %(95 % CI = 68.1 %~68.7 %),人群接种HPV疫苗原因主要是保护自身健康,人群中愿意为子女接种HPV疫苗的接种率为77.5 %(95 % CI = 68.9 %~86 %),人群不愿意接种HPV疫苗、不愿意为子女和自己、家人接种以及不愿意向别人推荐HPV的主要原因分别是疫苗安全性和有效性、HPV疫苗不了解、疫苗价格昂贵及对疫苗不太了解、担心说错而误导别人。人群愿意支付HPV疫苗的价格方式是政府支持HPV疫苗、上市后建议政府补贴76.2 %(95 % CI = 75.0 %~77.5 %),但是收入对HPV疫苗接种意愿影响不大。
      结论   人群对HPV疫苗接种意愿不高,为尽快加速实现人群消除宫颈癌的目标,后续需提高人群对HPV疫苗的相关认知。

     

    Abstract:
      Objective  To evaluate attitudes and behaviors of human papillomavirus (HPV) vaccine vaccination in mainland Chinese residents to provide evidences for promoting HPV vaccine vaccination in the population.
      Methods  We retrieved relevant researches on attitudes and behavioral factors of HPV vaccination among mainland Chinese residents published from January 1995 through January 2021 by searching the databases of PubMed, Medline, China National Knowledge Infrastructure (CNKI) and Wanfang Database. Two researchers independently screened the literatures and extracted the data; the literatures with literature quality score of greater than or equal to 5 were included into the analysis. Stata 12.0 software was adopted in statistical analyses.
      Results  Totally 52 literatures were included in the study, with a total of 91 762 respondents. The pooled results show that the overall ratio of the respondents reporting the willingness to have HPV vaccination is 66.4% (95% confidence interval 95% CI: 66.1% – 66.6%), with the highest ratio of 65.1% (95% CI: 56.9% – 73.4% ) among the respondents with the education of master degree or above and 68.4% (95% CI: 68.1% – 68.7%) among the respondents surveyed after 2016. Self-protection is a main reason for having HPV vaccination reported by the respondents. Of the respondents, 77.5% (95% CI: 68.9% – 86.0%) reported the willingness to have their children being vaccinated with HPV vaccine. The reported main reasons were without the knowledge about HPV vaccine and worrying about side effect of the vaccine for unwilling to have HPV vaccination, worrying about the safety and effectiveness of HPV vaccine for unwilling to have their children being vaccinated, high price of HPV vaccine for unwilling to have their family members being vaccinated, and without enough knowledge about HPV vaccine and worrying about misleading due to inaccurate interpretation for unwilling to recommend HPV vaccination to others, respectively. Of all the respondents, 76.2% (95% CI : 75.0% – 77.5%) suggested that the government should support HPV vaccination by providing subsidy. No significant impact of income on respondents′ HPV vaccination willingness was observed.
      Conclusion  The willingness to have HPV vaccination is not high among mainland Chinese residents. The awareness on HPV vaccine vaccination should be improved in the residents for the control of cervical cancer.

     

/

返回文章
返回